Role of PI3Kinase Gamma in Tumor Progression and Metastasis

PI3激酶γ在肿瘤进展和转移中的作用

• 批准号: 8828127
• 负责人: Judith A VARNER
• 金额: $ 42.02万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-04-01 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8828127
• 关键词: 1-Phosphatidylinositol 3-Kinase; Antigen Presentation; Biological Markers; Breast Cancer Treatment; Breast Carcinoma; Cell Adhesion; Cell Maturation; Chemical Agents; Chemicals; Chemotactic Factors; Chronic; Dendritic Cells; Development; Diagnostic; Disease; Endothelium; Exhibits; Family member; Functional disorder; G-Protein-Coupled Receptors; Gene Expression; Genes; Genetic; Goals; Growth; ITGAM gene; Immunity; Immunosuppression; Immunosuppressive Agents; Implant; Infectious Agent; Inflammation; Inflammatory; Integration Host Factors; Integrins; Interferons; Interleukin-1; Interleukin-1 Receptors; Interleukin-10; Interleukin-12; Interleukin-6; MYLK gene; Malignant Neoplasms; Mammary Neoplasms; Mediating; Molecular; Myelogenous; Myeloid Cell Activation; Myeloid Cells; Neoplasm Metastasis; Organ; Pathway interactions; Phenotype; Phosphotransferases; Physiological; Platelet-Derived Growth Factor; Play; Protein Isoforms; Publishing; Receptor Protein-Tyrosine Kinases; Regulation; Research; Risk; Role; Small Interfering RNA; Solid Neoplasm; Source; Suppressor-Effector T-Lymphocytes; Surrogate Markers; T-Cell Activation; Therapeutic; Toll-like receptors; Tumor Angiogenesis; Tumor Cell Invasion; Tumor Immunity; Tumor Suppression; Tumor-Derived; Vascular Endothelial Growth Factors; angiogenesis; arginase; blood vessel development; cancer cell; in vivo; inhibitor/antagonist; killer T cell; macrophage; mouse model; novel; oncology; prevent; therapeutic target; trafficking; tumor; tumor growth; tumor progression

DESCRIPTION (provided by applicant): Chronic inflammation promotes tumor development, as infectious and chemical agents, as well as chronic inflammatory disorders, have been shown to increase the risk of developing tumors. Solid tumors are heavily invested with tumor-associated macrophages, which promote angiogenesis, immunosuppression and tumor growth, progression, and metastasis. Targeting the mechanisms controlling myeloid cell recruitment to tumors is a promising approach to suppressing tumor growth and metastasis. We recently found that myeloid cell recruitment to tumors depends on PI3kinase ? (p110?). Pharmacological or genetic blockade of p110? suppressed myeloid cell adhesion to endothelium and recruitment to tumors, as well as angiogenesis, growth and metastasis of implanted and spontaneous tumors, revealing that p110? is an important therapeutic target in oncology. Importantly, p110? is the major PI3-kinase isoform expressed in myeloid cells; furthermore, myeloid cells are the main physiological source of p110?. Selective inhibitors of p110? could thus serve as therapeutics to suppress tumor malignancy by blocking diverse pathways promoting tumor inflammation. The aims of this proposal are 1) to determine the molecular pathways by which PI3kinase gamma regulates myeloid cell trafficking during inflammation, tumor progression and metastasis, 2) to evaluate the role of PI3K? in the regulation of immunosuppression during tumor progression, and 3) to evaluate the potential of PI3- kinase ? to serve as a therapeutic target for the treatment of breast cancer.

描述（由申请人提供）：慢性炎症促进肿瘤的发展，因为感染性和化学制剂以及慢性炎症性疾病已被证明会增加肿瘤发展的风险。实体肿瘤中大量存在与肿瘤相关的巨噬细胞，巨噬细胞促进血管生成、免疫抑制和肿瘤生长、进展和转移。针对骨髓细胞向肿瘤募集的机制是抑制肿瘤生长和转移的一种很有前途的方法。我们最近发现骨髓细胞向肿瘤的募集依赖于PI3kinase ？(p110吗?)药物或基因阻断p110？抑制骨髓细胞对内皮的粘附和肿瘤的募集，以及植入性和自发性肿瘤的血管生成、生长和转移，表明p110？是肿瘤重要的治疗靶点。重要的是,p110 ?是在髓细胞中表达的pi3激酶的主要亚型；此外，髓系细胞是p110的主要生理来源。p110？因此可以作为通过阻断促进肿瘤炎症的多种途径来抑制肿瘤恶性的治疗药物。本提案的目的是1)确定PI3K激酶γ在炎症、肿瘤进展和转移过程中调节髓细胞运输的分子途径；2)评估PI3K？在肿瘤进展过程中调节免疫抑制的作用；3)评估PI3-激酶？作为治疗乳腺癌的治疗靶点。